Joseph L. Kuti

Featured in: Favicon

tandfonline.com Favicon

physiciansweekly.com Favicon

onlinelibrary.wiley.com

Articles

Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms

Jul 1, 2024 | accpjournals.onlinelibrary.wiley.com | Christina Koenig |Joseph L. Kuti |Jacoby GA

CONFLICT OF INTEREST STATEMENT J.L.K. reports grants from Merck & Co, Inc, Shionogi, Entasis, the United States Food and Drug Administration, Biomeriuex, Roche, consulting fees and payment or honoraria for lectures from Shionogi. C.K. has received consulting fees and honoraria for lectures from Shionogi, Pfizer and Gilead, and reports grants from the DAMP and Joachim Herz Foundations. REFERENCES 1, , , .

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →